<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04193202</url>
  </required_header>
  <id_info>
    <org_study_id>7264-043</org_study_id>
    <secondary_id>2019-002308-42</secondary_id>
    <secondary_id>MK-7264-043</secondary_id>
    <nct_id>NCT04193202</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Gefapixant (MK-7264) in Adult Participants With Recent Onset Chronic Cough (MK-7264-043)</brief_title>
  <official_title>A Phase 3b Randomized, Double-blind, Placebo Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Gefapixant in Adult Participants With Recent Onset Chronic Cough</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Merck Sharp &amp; Dohme Corp.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy and safety of gefapixant in
      participants with recent onset chronic cough (duration &gt;8 weeks after onset of cough
      symptoms) for &lt;12 months and a diagnosis of refractory or unexplained chronic cough. The
      primary hypothesis is that gefapixant is superior to placebo in improving cough-related
      quality of life measured as change from baseline in the Leicester Cough Questionnaire (LCQ)
      total score at Week 12.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 21, 2020</start_date>
  <completion_date type="Anticipated">April 7, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 7, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in the Leicester Cough Questionnaire (LCQ) total score at Week 12</measure>
    <time_frame>Baseline, Week 12</time_frame>
    <description>Participants will be asked to complete the LCQ to assess the impact of their cough severity on health related quality of life (HRQoL) over the past 2 weeks. The LCQ is a 19-item, cough-specific HRQoL questionnaire. Each item on the LCQ assesses symptoms using a 7-point scale ranging from 1 to 7. The LCQ contains three domains on physical, psychological, and social functioning, and each domain score is calculated as the mean score of the items (range: 1 to 7) within the domain. The LCQ total score is the sum of the 3 domains, with a range from 3 (lowest total score) to 21 (highest total score). Higher scores indicate better HRQoL. The change from baseline in LCQ total score will be calculated.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in the Cough Severity Visual Analog Scale (VAS) score at Week 12</measure>
    <time_frame>Baseline, Week 12</time_frame>
    <description>Participants will be asked to complete the VAS questionnaire to assess the severity of their cough over the past 24-hours. The Cough Severity VAS is a single-item questionnaire asking the participant to rate the severity of their cough on a 100-point scale ranging from 0 (&quot;No Cough&quot;) to 100 (&quot;Extremely Severe Cough&quot;). Higher scores indicate greater severity of cough. The change from baseline in VAS score will be calculated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of participants with one or more adverse events (AEs)</measure>
    <time_frame>Up to ~Week 14</time_frame>
    <description>An AE is defined as any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. The percentage of participants with one or more AEs will be calculated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of participants who discontinue study drug due to an AE</measure>
    <time_frame>Up to Week 12</time_frame>
    <description>An AE is defined as any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. The percentage of participants who discontinue study drug due to an AE will be calculated.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">414</enrollment>
  <condition>Cough</condition>
  <arm_group>
    <arm_group_label>Gefapixant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive gefapixant at a dose of 45 mg administered as an oral tablet twice daily for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will receive placebo matching gefapixant, administered as an oral tablet twice daily for 12 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gefapixant</intervention_name>
    <description>Administered twice daily as an oral tablet of 45 mg</description>
    <arm_group_label>Gefapixant</arm_group_label>
    <other_name>MK-7264</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Administered twice daily as a placebo oral tablet matching gefapixant</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chest radiograph or computerized topography (CT) scan of the thorax performed after
             the onset of cough symptoms but before the diagnosis of chronic cough require
             consultation with the Sponsor to determine if acceptable for inclusion in study

          -  Has chronic cough (defined as duration of &gt;8 weeks after onset of cough symptoms) for
             &lt;12 months prior to the screening visit (&lt;14 months after onset of cough symptoms)

          -  Has a diagnosis of refractory chronic cough or unexplained chronic cough

          -  Female participants are not pregnant, not breastfeeding, not of childbearing
             potential, or agree to follow contraceptive guidance

        Exclusion Criteria:

          -  Is a current smoker

          -  Has given up smoking within 12 months of screening

          -  Is a former smoker with a smoking history greater than 20 pack-years (1 pack of 20
             cigarettes per day for 20 years)

          -  Has a history of respiratory tract infection or recent change in pulmonary status
             within 4 weeks of screening

          -  Has a history of chronic bronchitis, defined as cough that produces &gt;1 tablespoon of
             phlegm, that occurs every day for at least 3 months in a row

          -  Has a history of malignancy ≤5 years prior to signing informed consent except for
             adequately treated basal cell or squamous cell skin cancer or cervical cancer

          -  Is a user of recreational or illicit drugs or a recent history (within the last year)
             of drug or alcohol abuse

          -  Has a history of anaphylaxis or cutaneous adverse drug reaction to
             sulfonamide-containing drugs

          -  Has a known allergy to gefapixant or its excipients

          -  Has donated or lost ≥1 unit (~300 mL) of blood within 8 weeks prior to first dose of
             gefapixant

          -  Has previously received gefapixant

          -  Is currently participating or has participated in an interventional clinical study
             within 30 days of participating in this current study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Director</last_name>
    <role>Study Director</role>
    <affiliation>Merck Sharp &amp; Dohme Corp.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Toll Free Number</last_name>
    <phone>1-888-577-8839</phone>
    <email>Trialsites@merck.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Center for Clinical Trials, LLC ( Site 0035)</name>
      <address>
        <city>Paramount</city>
        <state>California</state>
        <zip>90723</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>562-633-5101</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Springfield Clinic, LLP ( Site 0018)</name>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62703</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>217528754124469</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chesapeake Clinical Research, Inc ( Site 0037)</name>
      <address>
        <city>White Marsh</city>
        <state>Maryland</state>
        <zip>21162</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>410-931-1966</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Albuquerque Clinical Trials ( Site 0030)</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>505-224-7407</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Montefiore Einstein Center ( Site 0022)</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10461</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>929-263-3262</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>American Health Research ( Site 0047)</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>704-926-8042</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinical Research Institute of Southern Oregon, PC ( Site 0028)</name>
      <address>
        <city>Medford</city>
        <state>Oregon</state>
        <zip>97504</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>541-858-1018</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>AAPRI Clinical Research Institute ( Site 0051)</name>
      <address>
        <city>Lincoln</city>
        <state>Rhode Island</state>
        <zip>02865</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>401-681-4960</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Allergic Disease and Asthma Center ( Site 0027)</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29607</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>8646273800221</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Diagnostics Research Group ( Site 0021)</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>210-692-7157</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Allergy &amp; Asthma Center ( Site 0001)</name>
      <address>
        <city>Waco</city>
        <state>Texas</state>
        <zip>76712</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>254-741-8151</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tidewater Physician Multispecialty Group, PC ( Site 0048)</name>
      <address>
        <city>Williamsburg</city>
        <state>Virginia</state>
        <zip>23188</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>757-707-3999</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bellingham Asthma &amp; Allergy ( Site 0011)</name>
      <address>
        <city>Bellingham</city>
        <state>Washington</state>
        <zip>98225</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>360-733-5733</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Diex Recherche Quebec Inc ( Site 0805)</name>
      <address>
        <city>Quebec</city>
        <zip>G1N 4V3</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>4186144142</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Specialisee en Allergie de la Capitale - CSAC ( Site 0800)</name>
      <address>
        <city>Quebec</city>
        <zip>G1V 4W2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>4186597741</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zentrum fuer ambulante pneumologische Forschung Marburg GbR ( Site 0910)</name>
      <address>
        <city>Marburg</city>
        <state>Hessen</state>
        <zip>35037</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+496421270723</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ballenberger Freytag Wenisch Institut fuer klinische Forschung GmbH ( Site 0917)</name>
      <address>
        <city>Neu-Isenburg</city>
        <state>Hessen</state>
        <zip>63263</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>00496102809710</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pneumologicum im Suedstadtforum ( Site 0916)</name>
      <address>
        <city>Hannover</city>
        <state>Niedersachsen</state>
        <zip>30173</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+495111691755</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pneumologisches Studienzentrum ( Site 0911)</name>
      <address>
        <city>Berlin</city>
        <zip>10969</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+4930259393817</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Celan SA ( Site 0500)</name>
      <address>
        <city>Guatemala</city>
        <zip>01010</zip>
        <country>Guatemala</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+50252012851</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinica Medica Especializada en Neumologia y Tisiologia ( Site 0504)</name>
      <address>
        <city>Guatemala</city>
        <zip>01010</zip>
        <country>Guatemala</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+50252086402</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinica Medica Especializada en Neumologia ( Site 0502)</name>
      <address>
        <city>Guatemala</city>
        <zip>01011</zip>
        <country>Guatemala</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+50255135640</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Private Clinic ( Site 0505)</name>
      <address>
        <city>Guatemala</city>
        <zip>01011</zip>
        <country>Guatemala</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+50252045740</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinica Privada Dr. Jose Francisco Flores Lopez ( Site 0503)</name>
      <address>
        <city>Guatemala</city>
        <zip>01015</zip>
        <country>Guatemala</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+50223857431</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Instituto De Alergias y Enfermedades Respiratorias ( Site 0501)</name>
      <address>
        <city>Guatemala</city>
        <zip>01015</zip>
        <country>Guatemala</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+50223857591</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wonju Severance Christian Hospital ( Site 1502)</name>
      <address>
        <city>Wonju-si</city>
        <state>Kang-won-do</state>
        <zip>26426</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+82-33-741-0540</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital ( Site 1501)</name>
      <address>
        <city>Seoul</city>
        <state>Seoul-teukbyeolsi [Seoul]</state>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+82220722971</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Severance Hospital Yonsei University Health System ( Site 1503)</name>
      <address>
        <city>Seoul</city>
        <state>Seoul-teukbyeolsi [Seoul]</state>
        <zip>03722</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+82-2-2228-1961</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinica Ricardo Palma ( Site 0601)</name>
      <address>
        <city>San Isidro</city>
        <state>Lima</state>
        <zip>15036</zip>
        <country>Peru</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+51993456447</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Asociacion Civil por la Salud ( Site 0602)</name>
      <address>
        <city>Lima</city>
        <zip>15046</zip>
        <country>Peru</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+51996495845</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne Pratia Bydgoszcz ( Site 1206)</name>
      <address>
        <city>Bydgoszcz</city>
        <state>Kujawsko-pomorskie</state>
        <zip>85-796</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+48734120500</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>NZOZ CENTRUM ALERGOLOGII ( Site 1207)</name>
      <address>
        <city>Lublin</city>
        <state>Lubelskie</state>
        <zip>20-552</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>814628882</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Specjalistyczny osrodek .All-Med. Grazyna Pulka ( Site 1203)</name>
      <address>
        <city>Krakow</city>
        <state>Malopolskie</state>
        <zip>30-033</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+43608623915</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>RCMed ( Site 1202)</name>
      <address>
        <city>Sochaczew</city>
        <state>Mazowieckie</state>
        <zip>96-500</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+48792000477</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne Pratia Katowice ( Site 1205)</name>
      <address>
        <city>Katowice</city>
        <state>Slaskie</state>
        <zip>40-081</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+48607931761</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne Silmedic Sp z o o ( Site 1204)</name>
      <address>
        <city>Katowice</city>
        <state>Slaskie</state>
        <zip>40-282</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+48607040304</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gyncentrum Clinic Sp. z o.o. ( Site 1208)</name>
      <address>
        <city>Katowice</city>
        <state>Slaskie</state>
        <zip>40-851</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+48504039300</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Clinical Hospital No. 3 them. M. A. Podgorbunskogo ( Site 1401)</name>
      <address>
        <city>Kemerovo</city>
        <state>Kemerovskaya Oblast'</state>
        <zip>650000</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+73842604019</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>GBUZ LO Center of Occupational Pathology ( Site 1447)</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Sankt-Peterburg</state>
        <zip>195271</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+79216476665</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>SEIHPE Saint Petersburg SMU ( Site 1435)</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Sankt-Peterburg</state>
        <zip>432063</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+79052528564</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>SPb SBHI City Consultative Diagnostic Center 1 ( Site 1409)</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Sankt-Peterburg</state>
        <zip>432063</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+79112904123</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Limited Liability Company Kurator ( Site 1425)</name>
      <address>
        <city>St. Petersburg</city>
        <state>Sankt-Peterburg</state>
        <zip>196240</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+79818518150</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>SBCIH of the Yaroslavl region Central city hospital ( Site 1429)</name>
      <address>
        <city>Yaroslavl</city>
        <state>Yaroslavskaya Oblast'</state>
        <zip>150040</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+79159752515</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario de Santiago ( Site 1820)</name>
      <address>
        <city>Santiago de Compostela</city>
        <state>A Coruna [La Coruna]</state>
        <zip>15706</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+34981951173</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario Gregorio Maranon ( Site 1823)</name>
      <address>
        <city>Madrid</city>
        <state>Madrid, Comunidad De</state>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+34915868326</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kherson City Clinical Hospital n.a. Y.Y. Karabelesh ( Site 2811)</name>
      <address>
        <city>Kherson</city>
        <state>Khersonska Oblast</state>
        <zip>73000</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+380500422845</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical Center of LLC Medical Clinic Blahomed ( Site 2815)</name>
      <address>
        <city>Kyiv</city>
        <state>Kyivska Oblast</state>
        <zip>01023</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+380936306646</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>SE Road Clinical Hospital 2 of Kyiv station ( Site 2812)</name>
      <address>
        <city>Kyiv</city>
        <state>Kyivska Oblast</state>
        <zip>03049</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+380997350900</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>F.G.Yanovskyy Institute of Phthisiology and Pulmonology ( Site 2802)</name>
      <address>
        <city>Kyiv</city>
        <state>Kyivska Oblast</state>
        <zip>03680</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+380975918014</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>F.G.Yanovskyy Institute of Phthisiology and Pulmonology ( Site 2808)</name>
      <address>
        <city>Kyiv</city>
        <state>Kyivska Oblast</state>
        <zip>03680</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+380633912378</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Odesa regional clinical hospital ( Site 2804)</name>
      <address>
        <city>Odesa</city>
        <state>Odeska Oblast</state>
        <zip>65025</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+380503907846</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Polyclinic N20 ( Site 2806)</name>
      <address>
        <city>Odesa</city>
        <state>Odeska Oblast</state>
        <zip>65114</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+380674826603</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Poltava City Clinical Hospital -1 ( Site 2813)</name>
      <address>
        <city>Poltava</city>
        <state>Poltavska Oblast</state>
        <zip>36039</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+380505858953</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vinnytsia Regional Clinical Hospital n.a. M.I. Pyrogov ( Site 2814)</name>
      <address>
        <city>Vinnytsia</city>
        <state>Vinnytska Oblast</state>
        <zip>21018</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+380432570572</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Private Small-Scale Enterprise Medical Centre &quot;Pulse&quot; ( Site 2809)</name>
      <address>
        <city>Vinnytsya</city>
        <state>Vinnytska Oblast</state>
        <zip>21001</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+380672522328</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Volyn Regional Clinical Hospital ( Site 2816)</name>
      <address>
        <city>Lutsk</city>
        <state>Volynska Oblast</state>
        <zip>43005</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+380505470790</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>MI Zaporizhzhia City Multispecialty Clinical Hospital 9 ( Site 2803)</name>
      <address>
        <city>Zaporizhzhia</city>
        <state>Zaporizka Oblast</state>
        <zip>69096</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+380507392440</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zhytomyr Central City Hospital #1 ( Site 2807)</name>
      <address>
        <city>Zhytomyr</city>
        <state>Zhytomyrska Oblast</state>
        <zip>10002</zip>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>+380505272203</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>MeDiNova Yorkshire Dedicated Research Centre ( Site 2715)</name>
      <address>
        <city>Shipley</city>
        <state>Bradford</state>
        <zip>BD18 3SA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Coordinator</last_name>
      <phone>07495600655</phone>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Germany</country>
    <country>Guatemala</country>
    <country>Korea, Republic of</country>
    <country>Peru</country>
    <country>Poland</country>
    <country>Russian Federation</country>
    <country>Spain</country>
    <country>Ukraine</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>December 9, 2019</study_first_submitted>
  <study_first_submitted_qc>December 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2019</study_first_posted>
  <last_update_submitted>July 23, 2020</last_update_submitted>
  <last_update_submitted_qc>July 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cough</keyword>
  <keyword>Respiration disorders</keyword>
  <keyword>Respiratory tract diseases</keyword>
  <keyword>Signs and symptoms, respiratory</keyword>
  <keyword>Signs and symptoms</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cough</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>http://engagezone.msd.com/doc/ProcedureAccessClinicalTrialData.pdf</ipd_description>
    <ipd_url>http://engagezone.msd.com/ds_documentation.php</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

